Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Associations of age at type 2 diabetes diagnosis with ethnicity and socioeconomic deprivation: observational study in 11.5 million people in England.

International journal for equity in health·2026
Same author

Dietary intake, fatty acid in adipose tissue and cardio-metabolic health: cross-sectional study from the TwinsUK cohort.

Nutrition & diabetes·2026
Same author

Diabetes in sub-Saharan Africa: aligning biology, culture, and health systems for improved outcomes.

The lancet. Diabetes & endocrinology·2026
Same author

Twenty-year trends in ethnicity with type 2 diabetes across age at diagnosis: observational study in 11 million individuals in England.

Nutrition, metabolism, and cardiovascular diseases : NMCD·2026
Same author

Diagnostic differences in glycemic markers for detecting impaired glucose tolerance in Black African and White European men in the United Kingdom: The SOUL-DEEP cross-sectional study.

Journal of diabetes investigation·2026
Same author

Temporal changes in first-phase ejection fraction during evolution of heart failure with preserved ejection fraction and afterload-induced heart failure in mice.

Journal of physiology and biochemistry·2026

Related Experiment Video

Updated: May 8, 2026

Measuring the Stiffness of Ex Vivo Mouse Aortas Using Atomic Force Microscopy
10:35

Measuring the Stiffness of Ex Vivo Mouse Aortas Using Atomic Force Microscopy

Published on: October 19, 2016

SFAs do not impair endothelial function and arterial stiffness.

Thomas A B Sanders1, Fiona J Lewis, Louise M Goff

  • 1Diabetes and Nutritional Sciences Division, King's College London, London, United Kingdom. tom.sanders@kcl.ac.uk

The American Journal of Clinical Nutrition
|August 22, 2013
PubMed
Summary

Replacing saturated fatty acids with monounsaturated fatty acids or carbohydrates does not impact vascular function or arterial stiffness in individuals with insulin resistance. This study found no significant differences in key vascular markers across dietary interventions.

More Related Videos

Measuring Ascending Aortic Stiffness In Vivo in Mice Using Ultrasound
10:08

Measuring Ascending Aortic Stiffness In Vivo in Mice Using Ultrasound

Published on: December 2, 2014

Pulse-Wave Velocity, Flow-Mediated Dilation, and Carotid Intima-Media Thickness to Assess Cardiovascular Risk in Population with Metabolic Syndrome
06:04

Pulse-Wave Velocity, Flow-Mediated Dilation, and Carotid Intima-Media Thickness to Assess Cardiovascular Risk in Population with Metabolic Syndrome

Published on: September 27, 2024

Related Experiment Videos

Last Updated: May 8, 2026

Measuring the Stiffness of Ex Vivo Mouse Aortas Using Atomic Force Microscopy
10:35

Measuring the Stiffness of Ex Vivo Mouse Aortas Using Atomic Force Microscopy

Published on: October 19, 2016

Measuring Ascending Aortic Stiffness In Vivo in Mice Using Ultrasound
10:08

Measuring Ascending Aortic Stiffness In Vivo in Mice Using Ultrasound

Published on: December 2, 2014

Pulse-Wave Velocity, Flow-Mediated Dilation, and Carotid Intima-Media Thickness to Assess Cardiovascular Risk in Population with Metabolic Syndrome
06:04

Pulse-Wave Velocity, Flow-Mediated Dilation, and Carotid Intima-Media Thickness to Assess Cardiovascular Risk in Population with Metabolic Syndrome

Published on: September 27, 2024

Area of Science:

  • Cardiovascular Health
  • Nutritional Science
  • Metabolic Research

Background:

  • Uncertainty exists regarding the impact of saturated fatty acids (SFAs) on endothelial function and arterial stiffening.
  • Investigating dietary modifications is crucial for understanding cardiovascular disease risk factors.

Purpose of the Study:

  • To determine the effects of substituting SFAs with monounsaturated fatty acids (MUFAs) or carbohydrates on endothelial function and arterial stiffness.
  • To assess changes in flow-mediated dilation (FMD), pulse wave velocity (PWV), and plasma 8-isoprostane F2α-III concentrations.

Main Methods:

  • A parallel-designed randomized controlled trial involving 121 participants with insulin resistance.
  • Dietary interventions included a high-SFA (HS) diet, a high-MUFA (HM) diet, and a high-carbohydrate (HC) diet for 24 weeks.
  • Vascular function was assessed by measuring FMD, PWV, and plasma 8-isoprostane F2α-III levels.

Main Results:

  • No significant differences in FMD, PWV, or plasma 8-isoprostane F2α-III concentrations were observed between the HS, HM, and HC diet groups after 6 months.
  • Changes in FMD ranged from -0.2% to +0.3%, PWV changes were between -1.0% and +2.7%, and 8-isoprostane F2α-III changes were between 1% and 6% across diets.
  • These findings indicate no adverse vascular effects from replacing SFAs with MUFAs or carbohydrates in this population.

Conclusions:

  • Replacing SFAs with MUFAs or carbohydrates does not appear to negatively affect vascular function in individuals with insulin resistance.
  • The study provides evidence that dietary fat composition, specifically SFA reduction, may not be a primary driver of vascular changes in this group.
  • Further research may explore long-term effects and different participant populations.